Alzghoul Bashar N, As Sayaideh Mohammad, Moreno Brian F, Singh Saminder K, Innabi Ayoub, Reddy Raju, Papierniak Eric S, Alnuaimat Hassan M
Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL, USA.
Dept of Medicine, University of Florida, Gainesville, FL, USA.
ERJ Open Res. 2021 Mar 8;7(1). doi: 10.1183/23120541.00772-2020. eCollection 2021 Jan.
The eosinophilic COPD phenotype is associated with greater airway remodelling, exacerbation risk and steroid responsiveness. However, little is known about the prevalence and characteristics of pulmonary hypertension (PH) in this patient population.
We retrospectively evaluated a cohort of COPD patients with right heart catheterisation (RHC) data at a university hospital between January 2011 and May 2019 and compared the pulmonary vascular profile and prevalence of PH between eosinophilic and noneosinophilic patients using a definition of eosinophilic COPD as at least three blood eosinophil values ≥300 cells·µL. We used multivariable logistic regression analyses to examine the association between eosinophilic COPD and various PH categories adjusting for age, sex, body mass index, forced expiratory volume in 1 s (%), smoking status and use of supplemental oxygen.
Among 106 COPD patients with RHC data and at least three blood eosinophil values, 25% met the definition of eosinophilic COPD. Fewer patients among the eosinophilic group required long-term oxygen therapy (69% 93%, p=0.001) and total lung capacity was significantly lower in the eosinophilic group (p=0.006). This group had higher mean pulmonary arterial pressure (mPAP) (median (interquartile range) 30 (27-41) mmHg 25 (22-30) mmHg, p=0.001) and pulmonary vascular resistance (PVR) (4 (2.8-5.1) Wood units 2.9 (2.1-4.1) Wood units, p=0.018). On multivariable logistic regression analyses, eosinophilic phenotype was associated with PH (adjusted (a)OR 6.5, 95% CI 1.4-30.7; p=0.018) and pre-capillary PH (aOR 3.2, 95% CI 1.1-9; p=0.027), but not severe PH (aOR 2.1, 95% CI 0.6-7.2; p=0.219).
Eosinophilic COPD was associated with higher mPAP and PVR and increased likelihood of PH. More studies are needed to further explore this finding.
嗜酸性粒细胞性慢性阻塞性肺疾病(COPD)表型与更严重的气道重塑、急性加重风险及类固醇反应性相关。然而,关于该患者群体中肺动脉高压(PH)的患病率及特征,人们知之甚少。
我们回顾性评估了2011年1月至2019年5月间在一家大学医院有右心导管检查(RHC)数据的COPD患者队列,并使用嗜酸性粒细胞性COPD的定义(至少三次血液嗜酸性粒细胞值≥300个细胞·μL)比较了嗜酸性粒细胞性和非嗜酸性粒细胞性患者的肺血管情况及PH患病率。我们使用多变量逻辑回归分析来检验嗜酸性粒细胞性COPD与各种PH类别之间的关联,并对年龄、性别、体重指数、1秒用力呼气量(%)、吸烟状况及补充氧气的使用情况进行了校正。
在106例有RHC数据且至少有三次血液嗜酸性粒细胞值的COPD患者中,25%符合嗜酸性粒细胞性COPD的定义。嗜酸性粒细胞性组中需要长期氧疗的患者较少(69%对93%,p = 0.001),且嗜酸性粒细胞性组的肺总量显著更低(p = 0.006)。该组的平均肺动脉压(mPAP)更高(中位数(四分位间距)30(27 - 41)mmHg对25(22 - 30)mmHg,p = 0.001),肺血管阻力(PVR)也更高(4(2.8 - 5.1)伍德单位对2.9(2.1 - 4.1)伍德单位,p = 0.018)。在多变量逻辑回归分析中,嗜酸性粒细胞性表型与PH相关(校正后(a)OR 6.5,95%CI 1.4 - 30.7;p = 0.018)及毛细血管前PH相关(aOR 3.2,95%CI 1.1 - 翻页继续9;p = 0.027),但与重度PH无关(aOR 2.1,95%CI 0.6 - 7.2;p = 0.219)。
嗜酸性粒细胞性COPD与更高的mPAP和PVR及PH发生可能性增加相关。需要更多研究来进一步探索这一发现。